Quantitative SSTR-PET/CT: a potential tool for predicting everolimus response in neuroendoctine tumour patients

ENETS Centre of Excellence, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System at the University Hospital of Munich (GEPNET-KUM), University Hospital of MunichMunich, Germany

Department of Internal Medicine 4, University Hospital, LMU MunichGermany

Johannes Rübenthaler

Department of Radiology, University Hospital, LMU MunichMunich, Germany

Jens Ricke

Department of Radiology, University Hospital, LMU MunichMunich, Germany

Maria Ingenerf

Department of Radiology, University Hospital, LMU MunichMunich, Germany

Christine Schmid-Tannwald

Department of Radiology, University Hospital, LMU MunichMunich, Germany

eISSN:: 1581-3207
Lingua:: Inglese

Frequenza di pubblicazione:: 4 volte all'anno
Argomenti della rivista:: Medicine, Clinical Medicine, Internal Medicine, Haematology, Oncology, Radiology

Feed RSS della rivista

Quantitative SSTR-PET/CT: a potential tool for predicting everolimus response in neuroendoctine tumour patients

Article Category: Research Article

Pubblicato online: 12 giu 2024

Pagine: -

Ricevuto: 12 mar 2024

Accettato: 10 mag 2024

DOI: https://doi.org/10.2478/raon-2024-0032

Parole chiaveneuroendocrine tumors, SSTR-PET/CT, everolimus, response

© 2024 Homeira Karim et al., published by Sciendo

This work is licensed under the Creative Commons Attribution 4.0 International License.

Parole chiave
neuroendocrine tumors, SSTR-PET/CT, everolimus, response